Financials
- Financial year
- 2025
- Total assets
- €972,793
- Profit
- €500,026
- Solvency
- 99.1%
Total assets▼ 0.8%
Net result
20182025
BIPHARMA
InactiveOverview
Activity
Activity not known
Size
€972,793total assets 2025
- Equity
- €963,676
- Profit
- €500,026
Turnover not published (abbreviated format)
Financial health
Inactive: no score
Structure
2 of 8 deeds read
SignalsneutralLatest accounts filed on timeShow the evidence
Signals
1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
52 days early
2024
8 days late
2023
27 days late
2022
30 days late
2021
61 days late
2020
18 days late
2019
27 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 7 accounts on average 17 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (1)
- Resignations & appointments · End &…Resignations: DE VOGEL Paulus (director)…
- Annual accounts filedfinancial year 2025 · abbreviated…
- Highest result from 2018 to 2025net €500,026 ▲158%
Key points
By topic
Timeline
- Events
- 24
- Since
- 2008
- 31-12-2025Liquidity more than 18 times
- 08-08-2025Annual accounts filed
- 27-08-2024Annual accounts filed
Company details
- Legal form
- Public limited company
- Year ends
- 31-12
- Peppol
- Still in the Peppol directory
Articles of association
- Provisions read
- 1
See the provisions in the deeds
Go to Articles of associationGo further with this company
What became of the directors' other companies?Supplier due diligence Who ran this company, and where was it based, on a given date before it ended?Company as of a date
Investigating this company? Keep it with today's facts in a case file.